✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Astal Laboratories Ltd.

ASTALLTD

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹89 Cr.
P/E
8.95

Astal Laboratories Ltd.

  • Astal Laboratories
  • Rajlaxmi Industries
  • Novelix Pharma

FAQs on Astal Laboratories Ltd. Shareprice

Astal Laboratories has given better returns compared to its competitors.
Astal Laboratories has grown at ~36.79% over the last 7yrs while peers have grown at a median rate of 29.05%

Astal Laboratories is not expensive.
Latest PE of Astal Laboratories is 8.95, while 3 year average PE is 96.7.
Also latest EV/EBITDA of Astal Laboratories is 6.66 while 3yr average is 7.43.

View FAQ's On Business

Growth Table

  • Astal Laboratories Ltd.
  • Rajlaxmi Industries
  • Novelix Pharma

Balance Sheet

  • Astal Laboratories Ltd.
  • Rajlaxmi Industries
  • Novelix Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Astal Laboratories Ltd.
  • Rajlaxmi Industries
  • Novelix Pharma

Cash Flow

  • Astal Laboratories Ltd.
  • Rajlaxmi Industries
  • Novelix Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Astal Laboratories Ltd.
  • Rajlaxmi Industries
  • Novelix Pharma

Quarterly Results

  • Astal Laboratories Ltd.
  • Rajlaxmi Industries
  • Novelix Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Astal Laboratories Ltd. Financials

Balance sheet of Astal Laboratories is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Astal Laboratories is decreasing.
Latest net debt of Astal Laboratories is ₹7.75 Crs as of Sep-25.
This is less than Mar-25 when it was ₹9.81 Crs.

Yes, profit is increasing.
The profit of Astal Laboratories is ₹9.91 Crs for TTM, ₹8.93 Crs for Mar 2025 and ₹0.78 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Astal Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech